Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)

ClinicalTrials.gov ID: NCT00621478

Public ClinicalTrials.gov record NCT00621478. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Use Of Lorazepam For The Treatment Of Pediatric Status Epilepticus: A Randomized, Double-Blinded Trial Of Lorazepam And Diazepam

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Children with seizures are frequently seen in the emergency department. The drug lorazepam, which is commonly used, is not labeled by the US Food and Drug Administration for children for this use. The FDA, under the Best Pharmaceuticals for Children Act, has requested that a study comparing diazepam, a drug that is labeled by the FDA for this indication, with lorazepam be performed. The study will show whether one drug is more effective and safe than the other.

Study identification

NCT ID
NCT00621478
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Enrollment
259 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Months to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2008 (Type not available)
Primary completion
May 2012 (Actual)
Completion
May 2012 (Actual)
Last update posted
Dec 18, 2012

2008 – 2012

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
University of California- Davis Medical Center Davis California 95817 —
Children's Hospital Colorado Aurora Colorado 80045 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
University of Maryland Hospital for Children Baltimore Maryland 21201 —
University of Michigan Emergency Medicine Research Ann Arbor Michigan 48106 —
Children's Hospital of Michigan Detroit Michigan 48201 —
Children's Hospital of Buffalo Buffalo New York 14222 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Medical Center Dallas Dallas Texas 75390-9063 —
Texas Children's Hospital Houston Texas 77030 —
University of Utah Pediatric Emergency Medicine Salt Lake City Utah 84158 —
Medical College of Wisconsin Children's Corporate Center Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00621478, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2012 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00621478 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →